Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
nandrolone decanoate, Quantity: 50 mg/mL
Aspen Pharmacare Australia Pty Ltd
Nandrolone decanoate
Injection, solution
Excipient Ingredients: Arachis Oil; benzyl alcohol
Intramuscular
1 ampoule
(S4) Prescription Only Medicine
INDICATIONS AS AT 16 APRIL 1997. Acute renal failure, chronic renal insufficiency and anaemia of chronic renal failure. For the palliative treatment of inoperable mammary carcinoma. Osteoporosis (where oestrogen therapy is contraindicated). Aplastic anaemia. Patients on long-term treatment with corticosteriods.
Visual Identification: Clear oily liquid; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-03-08
-1- PRODUCT INFORMATION DECA-DURABOLIN ® _(nandrolone decanoate)_ NAME OF THE MEDICINE DECA-DURABOLIN ® 50 MG/ML (Solution for injection of nandrolone decanoate) _Molecular Formula: C_ _28_ _H_ _44_ _O_ _3 _ _Molecular mass: 428.7 Cas. No: 360-70-3_ _Chemical Name: _ _3-oxo-estr-4-en-17_ β _-yl _ _decanoate_ Deca-Durabolin is an androgenic oily preparation for intramuscular administration. DESCRIPTION Nandrolone decanoate is a white to creamy white, crystalline powder. It is practically insoluble in water but is freely soluble in chloroform, ethanol, ether, fixed oils and esters. Deca-Durabolin comes in glass ampoules containing 1 mL of light yellow oily liquid. Each ampoule contains 1 ml of 50 mg/mL nandrolone decanoate. COMPOSITION Each ml of Deca-Durabolin contains 50 mg of the active ingredient nandrolone decanoate. The product also contains the inactive ingredients benzyl alcohol (0.1 mL) and arachis (peanut) oil making up the volume. PHARMACOLOGY PHARMACODYNAMIC PROPERTIES Deca-Durabolin is an injectable anabolic preparation. The pharmacologically active substance is nandrolone. The decanoate ester gives the preparation a duration of action of about three weeks after injection. Nandrolone is chemically related to the male hormone. Compared to testosterone, it has an enhanced anabolic and a reduced androgenic activity. This has been demonstrated in animal bioassays and explained by receptor binding studies. The low androgenicity of nandrolone is confirmed in clinical use. In the human, Deca-Durabolin has been shown to positively influence calcium metabolism and to increase bone mass in osteoporosis. In women with disseminated mammary carcinoma, Deca- Durabolin has been reported to produce objective regressions for many months. Furthermore, Deca- Durabolin has a nitrogen-saving action. This effect on protein metabolism has been established by -2- metabolic studies and is utilised therapeutically in conditions where a protein deficiency exists such as during chronic debilitating diseases and after major sur Read the complete document